caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1942380290

Daniel FeigM.D., PH.D

Pediatric MedicineBirmingham, ALI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
QUALITY · MIPS · 2024
No data available for this provider in 2024.
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
Total received
$75
Payment records
3
By payment type
Food and Beverage$75
PRESCRIBING · PART D · 2024
Total Rx claims
94
Beneficiaries
—
Total drug cost
$45K
Distinct drugs
5
Brand share
36.2%
Top prescribed drugs
Sevelamer Carbonate26 claims
Lisinopril23 claims
Lisinopril12 claims
Amlodipine Besylate11 claims
Prednisone11 claims
REFERRAL NETWORK

Where Daniel Feig's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 3 inbound referrers · 0 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
THE CHILDREN'S HOSPITAL OF ALABAMA32591
Sahar Fathallah-Shaykh
Pediatric Medicine · Birmingham, AL
18274
David Askenazi
Pediatric Medicine · Birmingham, AL
1293
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
20
Unique beneficiaries
—
Total services
39
Distinct HCPCS
1
Medicare payment
$2K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 20 Pediatric Medicine providers in AL — above median (cohort median 129).